New York-Presbyterian Hospital
Quest Diagnostics to Acquire Parts of NewYork-Presbyterian Lab Business
The company will obtain lab assets in New York City and the Tri-State Area, while NewYork-Presbyterian will continue to operate certain hospital lab services.
Over the next year or so, the investigators plan to sequence the genomes of 3,000 patients with cancer, heart disease, diabetes, or neurological disorders.
Illumina, New York Healthcare Providers, NYGC Partner on Clinical Whole-Genome Sequencing
Weill Cornell Medicine, New York-Presbyterian Hospital, and the New York Genome Center will join Illumina to sequence the genomes of thousands of patients.